Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Apr 1 2025 | Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM Industry News In The News Industry Read More Mar 27 2025 | Highnoon Labs’ Commits to Advancing Heart Failure Care Through HFSA’s OMT-HF Certificate Program HFSA News Provider Education Read More Mar 27 2025 | BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions Industry News In The News Industry Read More Mar 19 2025 | Request for Proposal (RFP): Implementation of Artificial Intelligence (AI) in Cardiovascular Care Industry News In The News Industry Read More Mar 17 2025 | U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40% Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Page 23 Page 24 … Next page Next › Last page Last »
Apr 1 2025 | Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM Industry News In The News Industry Read More
Mar 27 2025 | Highnoon Labs’ Commits to Advancing Heart Failure Care Through HFSA’s OMT-HF Certificate Program HFSA News Provider Education Read More
Mar 27 2025 | BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions Industry News In The News Industry Read More
Mar 19 2025 | Request for Proposal (RFP): Implementation of Artificial Intelligence (AI) in Cardiovascular Care Industry News In The News Industry Read More
Mar 17 2025 | U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40% Industry News In The News Industry Read More
